In the spreadsheet above I have tracked the earnings estimates for the Nasdaq Biotech ETF (IBB) top 30 weighted stocks.
The column under the date 5/20/2021 has a letter that represents the movement in 2021 earnings estimates since the most recent print (3/20/2021). “U” means 2021 estimates are UP in the last 60 days. “D” means 2021 estimates are DOWN in the last 60 days. “S” means 2021 estimates have remained the SAME in the last 60 days. The column entitled “1yr Target Est” is the Wall Street consensus 12 month price target for each stock.
What this table is telling us is that estimates have come down in the past 60 days. More estimates came DOWN for 2021 in the past 60 days than went UP. UP:DOWN 11:19 ratio.
The cumulative 2021 earnings power of these 30 stocks was revised DOWN by -4.9% in the past 60 days. HOWEVER, the cumulative 2022 earnings power of these 30 stocks was revised UP by +5.03% in the past 60 days.
